Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 צפיות
• 07/04/23
0
0
לְשַׁבֵּץ
administrator
מנויים
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
© 2018 NACCME, an HMP Company
להראות יותר
תגובות בפייסבוק
SORT BY-
תגובות ראשיות
-
תגובות אחרונות